Hydrocodone cough suppressants will be taken off the market.
January 1
The FDA will be pulling unapproved hydrocodone cough suppressants from the market.
The withdrawal mostly concerns hydrocodone cough preps with guaifenesin (Hycotus, etc) or with homatropine PLUS an expectorant or decongestant (Histinex, etc).
These drugs came on the market before proof of efficacy and safety was required. Some of the unapproved products are also inappropriately labeled for use in children as young as 2-years-old. Hydrocodone cough suppressants have not been proven safe or effective for children under 6-years-old.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote